Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124124013 | 12412401 | 3 | F | 20160714 | 20160527 | 20160719 | EXP | US-PFIZER INC-2016274551 | PFIZER | ISKANDAR, J.. TRANSIENT AGRANULOCYTOSIS ASSOCIATED WITH ZIPRASIDONE IN A 45-YEAR-OLD MAN ON HEMODIALYSIS. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2015;35(3):347-348 | 45.00 | YR | M | Y | 0.00000 | 20160719 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124124013 | 12412401 | 1 | PS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 80 MG, 2X/DAY | Y | Y | 20825 | 80 | MG | BID | |||||
| 124124013 | 12412401 | 2 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 20 MG, 2X/DAY | Y | Y | 20825 | 20 | MG | BID | |||||
| 124124013 | 12412401 | 3 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 80 MG, 2X/DAY | Y | Y | 20825 | 80 | MG | BID | |||||
| 124124013 | 12412401 | 4 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 40 MG, 2X/DAY (BEFORE HEMODIALYSIS WAS INITIATED) | Y | Y | 20825 | 40 | MG | BID | |||||
| 124124013 | 12412401 | 5 | SS | GEODON | ZIPRASIDONE HYDROCHLORIDEIPRASIDONE MESYLATE | 1 | Oral | 80 MG, 2X/DAY | Y | Y | 20825 | 80 | MG | BID | |||||
| 124124013 | 12412401 | 6 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 124124013 | 12412401 | 7 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 124124013 | 12412401 | 8 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 124124013 | 12412401 | 9 | C | INSULIN GLARGINE | INSULIN GLARGINE | 1 | UNK | 0 | |||||||||||
| 124124013 | 12412401 | 10 | C | CALCITRIOL. | CALCITRIOL | 1 | UNK | 0 | |||||||||||
| 124124013 | 12412401 | 11 | C | ALBUTEROL /00139501/ | ALBUTEROL | 1 | UNK | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124124013 | 12412401 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124124013 | 12412401 | Agranulocytosis | Agranulocytosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |